Cem Kaan Parsak

Cem Kaan Parsak

Auto-generated profile, based on publicly available information

Cem Kaan Parsak

Department of General Surgery, Faculty of Medicine, Çukurova University, Balcalı Hospital, 01330 Adana, Türkiye

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 November 2007 in World Journal of Surgery
Verified
Journal Article
Closed access
PDF file
CPCem Kaan Parsak
Cem Kaan Parsak
GSGulsah Seydaoglu
Gulsah Seydaoglu
GSGurhan Sakman
Gurhan Sakman
TAT. Oguz Acarturk
T. Oguz Acarturk
EKEmre Karakoc
Emre Karakoc
SSSalim Satar
Salim Satar

1 January 2008
Verified
Journal Article
Closed access
SYSüleyman Yazar
Süleyman Yazar
ATAysegul Taylan-Ozkan
Aysegul Taylan-Ozkan
MHMurat Hökelek
Murat Hökelek
EPErdal Polat
Erdal Polat
HYHasan Yilmaz
Hasan Yilmaz
TATarik Artiş
Tarik Artiş


1 April 2023 in Clinical Science of Nutrition
Verified
Journal Article
Closed access
MDMUTLU DOGANAY
MUTLU DOGANAY
KAKezban Akçay
Kezban Akçay
TCTimucin Cil
Timucin Cil
BDBirgül Dağ
Birgül Dağ
KDKubilay Demirağ
Kubilay Demirağ
OAOsman Abbasoğlu
Osman Abbasoğlu
Beslenme desteği, hasta tedavisinin ayrılmaz bir parçasıdır. Bununla birlikte, günlük uygulamalarda beslenme tedavisi hedeflerine ulaşıldığını söylemek zordur. Bu nedenle klinik pratikte beslenme tedavisi uygulamalarını kolaylaştırmaya yönelik girişimlere ihtiyaç vardır. Malnütrisyon tedavisinde ilk seçenekler diyet düzenlemesi ve oral tamamlayıcı nütrisyon ürünleri kullanımıdır. Ancak oral yolla beslenemeyen veya beslenme hedeflerine ulaşılamayan bazı hasta gruplarında tüple beslenme ihtiyacı gerekmektedir. Tüm dünyada tıp fakültesi, beslenme ve diyetetik fakültesi ve uzmanlık eğitimi müfredatları klinik beslenme konusunda genellikle yeterli değildir. Hekim, diyetisyen, hemşire, eczacı ve diğer sağlık profesyonellerine yönelik, enteral beslenme kullanım endikasyonları, uygulanma şekilleri, ürünlerin seçimi, hasta izlemi, komplikasyonların yönetimi ve tedavi sonlandırılmasında yol gösterecek kısa, net ve pratik önerilere odaklı bir rehberin yararlı olacağını düşündük. Bu rehber, alanında deneyimli uzman bir ekip tarafından KEPAN çatısı altında hazırlanmış ve 29 kişiden oluşan KEPAN rehber grubunca onaylanmıştır.

24 January 2008 in Case Reports in Gastroenterology
Verified
Journal Article
Open access
PDF file
CPCem Kaan Parsak
Cem Kaan Parsak
IHIsmail Hanta
Ismail Hanta
AAAhmet Aslan
Ahmet Aslan
OAOmer Alabaz
Omer Alabaz
Hepatic tuberculosis is a rare manifestation of extra-pulmonary tuberculosis. Hepatic tuberculous lesions are especially mimicking tumour-like mass or cystic lesions in the liver and so can be misdiagnosed with several diseases. Histopathological examination of the specimen is essential in the diagnosis for hepatic tuberculosis. In this report, two cases with hepatic tuberculosis having cystic solid mass and abscess liver lesions are described.

3 July 2023 in European Journal of Breast Health
Verified
Journal Article
Closed access
IBIbrahim Boga
Ibrahim Boga
SSSebnem Ozemri Sag
Sebnem Ozemri Sag
NDNilgun Duman
Nilgun Duman
SOSevda Yesim Ozdemir
Sevda Yesim Ozdemir
Mahmut Cerkez ErgorenMahmut Cerkez Ergoren
Mahmut Cerkez Ergoren
STSEHIME TEMEL
SEHIME TEMEL
Breast cancer (BC) is the most common cancer type in women and may be inherited, mostly in an autosomal dominant pattern. The clinical diagnosis of BC relies on the published diagnostic criteria, and analysis of two genes, BRCA1 and BRCA2, which are strongly associated with BC, are included in these criteria. The aim of this study was to compare BC index cases with non-BC individuals in terms of genotype and diagnostic features to investigate the genotype/demographic information association. Mutational analyses for the BRCA1/BRCA2 genes was performed in 2475 individuals between 2013-2022 from collaborative centers across Turkey, of whom 1444 with BC were designated as index cases. Overall, mutations were identified in 17% (421/2475), while the percentage of mutation carriers in cases of BC was similar, 16.6% (239/1444). BRCA1/BRCA2 gene mutations were detected in 17.8% (131/737) of familial cases and 12% (78/549) of sporadic cases. Mutations in BRCA1 were found in 4.9%, whereas 12% were in BRCA2 (p<0.05). Meta-analyses were performed to compare these results with other studies of Mediterranean-region populations. Patients with BRCA2 mutations were significantly more common than those with BRCA1 mutations. In sporadic cases, there was a lower proportion with BRCA1/BRCA2 variants, as expected, and these results were consistent with the data of Mediterranean-region populations. However, the present study, because of the large sample size, revealed more robust findings than previous studies. These findings may be helpful in facilitating the clinical management of BC for both familial and non-familial cases.